Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Tower Engages Simone Capital for Investor Relations Services
-
The Precision Peptide Company Opens Nationwide Retail Sales Days After FDA Panel Backs Six of Seven Peptides Under Review
-
California Nanotechnologies Announces Q1 2027 Results
-
Obsidian Energy Announces Second Quarter 2026 Results
-
Cybeats' Channel Partnership Drives Commercial Win with Japanese Industrial Control Systems Leader
-
Antimony Resources Corp. (ATMY) (ATMYF) (K8J0) Reports High-Grade Assays from the latest drilling at the Main Zone - Bald Hill, including 11.41% Antimony (Sb) over 1.5 meters in BH-26-14 in a zone of
-
White Paper Examines Early Clinical Development of B-Cell Depletion Therapies in Autoimmune Disease
-
Temas and SAGA Successfully Validate RCL Technology With Titanium Recoveries of Up to 90.8% and Vanadium Recoveries of 97.4%
-
Electrovaya Launches ElvaPulse(TM) 1500 High-Power Energy Storage Platform for Data Center and Mission-Critical Power Applications
-
CoTec Holdings Corp. Investment MagIron Strengthens Leadership Team and Liquidity Position
-
Sun Peak Metals Advances Multi-Project Exploration Program in Saudi Arabia - Drill Programs Complete on First Two Projects, Assays Pending
-
Toast Across Mountains and Seas, World Raises Glass Together - Invitation to Laoshan Venue of 36th Qingdao Int'l Beer Festival
-
LKQ Corporation Announces Results for Second Quarter 2026
-
Toast Across Mountains and Seas, World Raises Glass Together - Invitation to Laoshan Venue of 36th Qingdao Int'l Beer Festival
-
Fancamp and Goldera Complete Spin-Out Transaction and $5.5 Million Financing in Goldera; to Commence Trading August 5, 2026
-
Lightspeed Announces First Quarter 2027 Financial Results
-
Hot Chili Quarterly Report - Period Ending 30 June 2026
-
Grounded Lithium Announces June Oil Sales and Secures Loans to Fund Oil & Gas Facility Improvements
-
EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)
-
Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026
-
Hamilton Lane Serves as Sole Lead Investor in Cynosure Partners' Single-Asset Continuation Vehicle
-
Atavistik Bio Partners with Cure HHT Clinical Trial Network to Advance Development of ATV-1601 for Hereditary Hemorrhagic Telangiectasia
-
Hershey Declares Quarterly Dividends
-
Blue Owl Capital Inc. Second Quarter 2026 Results
-
Hippo Reports Second Quarter 2026 Financial Results
-
REV Appoints Chief Operating Officer
-
Altria Reports 2026 Second-Quarter and First-Half Results; Narrows 2026 Full-Year Earnings Guidance
-
International Paper Reports Second Quarter 2026 Results
-
Hilton Grand Vacations Reports Second Quarter 2026 Results
-
DFIN Reports Second-Quarter 2026 Results
-
Terex Reports Second Quarter 2026 Results
-
Virtus Investment Partners Announces Financial Results for Second Quarter 2026
-
Webull Adds Benzinga's Premium Newsfeed, Press Releases and Economic Calendar
-
Republic Airways Holdings Inc. Announces Q2 2026 Financial Results And Increases Full Year Guidance
-
Myers Industries Announces 2026 Second Quarter Results
-
Madison Air Reports Second Quarter 2026 Results
-
Catalyst Bancorp, Inc. Announces 2026 Second Quarter Results
-
Oil States Announces Second Quarter 2026 Results
-
Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
-
Akido Announces the First AI-Native Health System in the US
-
Evogene Schedules Second Quarter 2026 Financial Results Release
-
Cytactic Welcomes Cybercrime Pioneer Shawn J. Chen to Advisory Board Following Strategic Investment
-
Daqo New Energy Issues Its 2025 Environmental, Social and Governance (ESG) Report
-
OneWater Marine Inc. Announces Fiscal Third Quarter 2026 Results
-
Announcing Trimble Dimensions 2026 User Conference and Offsite Expo
-
Dream Finders Homes Announces Second Quarter 2026 Results
-
Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
-
CREATE Medicines Receives Approval to Initiate First-in-Human Phase 1/2 Clinical Trial of In Vivo CAR-T Candidate CRT-402 for Autoimmune Diseases
-
Xtract One Technologies Expands California Healthcare Footprint With Multiple Deployments Across the State
-
Cargo Theft Jumped 60 Percent Last Year. The Tactics Changed Even Faster

